Barr Labs 2Q Net 27c A Share On 4c Charge Vs 10c
Earnings almost tripled!
Dow Jones Newswires
Barr Labs - Pomona, N.Y.
2nd Quar Dec. 31:
1997 1996
Revenues $92,328,000 $67,335,000
Net income a 6,325,000 2,228,000
Shr earns (diluted**)
Net income a .27 .10
6 Months:
Revenues 188,595,000 131,566,000
Net income a 16,722,000 3,995,000
Shr earns (diluted)
Net income a .72 .18
a. Includes loss of 4 cents a share from early extinguishment of debt.
Excluding loss, net income was 31 cents a share for the quarter and 76
cents a share for the six-month period.
* - 'Basic' earnings per share is calculated by dividing net earnings
applicable to common shares by common shares outstanding. This
replaces 'primary' earnings per share, which include common stock
equivalents in the calculation. The year ago per share amounts are
restated to reflect the current presentation.
Barr Labs Inc. (BRL) develops generic drugs to treat illnesses such as
cancer, heart disease, depression and hypertension. |
